Anti-glomerular basement membrane antibody-induced inflammation in rat cochlear plexus

Area of Science:

• Immunology
• Otolaryngology
• Pharmacology

Background:

• Autoimmune inner ear diseases are emerging causes of hearing loss.
• The precise mechanisms driving this hearing loss remain largely unknown.
• Establishing reliable models is crucial for understanding and treating these conditions.

Purpose of the Study:

• To develop a rat model of autoimmune-induced cochlear inflammation.
• To investigate the role of anti-basement membrane antibodies in cochlear inflammation.
• To evaluate the efficacy of prednisolone in mitigating this inflammation.

Main Methods:

• Lewis rats were immunized with rabbit IgG and injected with anti-rat glomerular basement membrane antibody.
• Immunofluorescence microscopy was used to detect antibody binding and inflammatory cell infiltration in the cochlear plexus.
• Flow cytometry was used to quantify CD4-positive T cells and monocytes/macrophages.

Main Results:

• Specific binding of anti-GBM antibody to cochlear capillary basement membranes was confirmed.
• Significant infiltration of CD4-positive T cells and monocytes/macrophages was observed in the cochlear plexus.
• Prednisolone treatment significantly suppressed the infiltration of both cell types.

Conclusions:

• Autoimmune inflammation in the cochlea can be induced by anti-basement membrane antibodies targeting cochlear capillaries.
• This model effectively demonstrates inflammatory processes relevant to autoimmune inner ear disease.
• Prednisolone shows potential as a therapeutic agent for reducing cochlear inflammation in autoimmune conditions.